Dendrimer-based drug and imaging conjugates: design considerations for nanomedical applications AR Menjoge, RM Kannan, DA Tomalia Drug discovery today 15 (5-6), 171-185, 2010 | 921 | 2010 |
Drug complexation, in vitro release and cellular entry of dendrimers and hyperbranched polymers P Kolhe, E Misra, RM Kannan, S Kannan, M Lieh-Lai International journal of pharmaceutics 259 (1-2), 143-160, 2003 | 569 | 2003 |
Emerging concepts in dendrimer‐based nanomedicine: from design principles to clinical applications RM Kannan, E Nance, S Kannan, DA Tomalia Journal of internal medicine 276 (6), 579-617, 2014 | 543 | 2014 |
The effect of surface functionality on cellular trafficking of dendrimers OP Perumal, R Inapagolla, S Kannan, RM Kannan Biomaterials 29 (24-25), 3469-3476, 2008 | 434 | 2008 |
Dendrimer-based postnatal therapy for neuroinflammation and cerebral palsy in a rabbit model S Kannan, H Dai, RS Navath, B Balakrishnan, A Jyoti, J Janisse, ... Science translational medicine 4 (130), 130ra46-130ra46, 2012 | 386 | 2012 |
Improvement in ductility of chitosan through blending and copolymerization with PEG: FTIR investigation of molecular interactions P Kolhe, RM Kannan Biomacromolecules 4 (1), 173-180, 2003 | 357 | 2003 |
Poly (amidoamine) dendrimer–drug conjugates with disulfide linkages for intracellular drug delivery YE Kurtoglu, RS Navath, B Wang, S Kannan, R Romero, RM Kannan Biomaterials 30 (11), 2112-2121, 2009 | 258 | 2009 |
Preparation, cellular transport, and activity of polyamidoamine-based dendritic nanodevices with a high drug payload P Kolhe, J Khandare, O Pillai, S Kannan, M Lieh-Lai, RM Kannan Biomaterials 27 (4), 660-669, 2006 | 230 | 2006 |
Activity of dendrimer− methotrexate conjugates on methotrexate-sensitive and-resistant cell lines S Gurdag, J Khandare, S Stapels, LH Matherly, RM Kannan Bioconjugate chemistry 17 (2), 275-283, 2006 | 222 | 2006 |
Drug release characteristics of PAMAM dendrimer–drug conjugates with different linkers YE Kurtoglu, MK Mishra, S Kannan, RM Kannan International journal of pharmaceutics 384 (1-2), 189-194, 2010 | 214 | 2010 |
Dendrimer-based targeted intravitreal therapy for sustained attenuation of neuroinflammation in retinal degeneration R Iezzi, BR Guru, IV Glybina, MK Mishra, A Kennedy, RM Kannan Biomaterials 33 (3), 979-988, 2012 | 211 | 2012 |
Dendrimer− drug conjugates for tailored intracellular drug release based on glutathione levels RS Navath, YE Kurtoglu, B Wang, S Kannan, R Romero, RM Kannan Bioconjugate chemistry 19 (12), 2446-2455, 2008 | 210 | 2008 |
Synthesis, cellular transport, and activity of polyamidoamine dendrimer− methylprednisolone conjugates J Khandare, P Kolhe, O Pillai, S Kannan, M Lieh-Lai, RM Kannan Bioconjugate chemistry 16 (2), 330-337, 2005 | 209 | 2005 |
Inhibition of bacterial growth and intramniotic infection in a guinea pig model of chorioamnionitis using PAMAM dendrimers B Wang, RS Navath, AR Menjoge, B Balakrishnan, R Bellair, H Dai, ... International journal of pharmaceutics 395 (1-2), 298-308, 2010 | 169 | 2010 |
Dendrimer brain uptake and targeted therapy for brain injury in a large animal model of hypothermic circulatory arrest MK Mishra, CA Beaty, WG Lesniak, SP Kambhampati, F Zhang, ... ACS nano 8 (3), 2134-2147, 2014 | 162 | 2014 |
Dynamics of cellular entry and drug delivery by dendritic polymers into human lung epithelial carcinoma cells S Kannan, P Kolhe, V Raykova, M Glibatec, RM Kannan, M Lieh-Lai, ... Journal of Biomaterials Science, Polymer Edition 15 (3), 311-330, 2004 | 156 | 2004 |
Nanotechnology approaches for ocular drug delivery Q Xu, SP Kambhampati, RM Kannan Middle East African journal of ophthalmology 20 (1), 26-37, 2013 | 144 | 2013 |
Subconjunctival injectable dendrimer-dexamethasone gel for the treatment of corneal inflammation U Soiberman, SP Kambhampati, T Wu, MK Mishra, Y Oh, R Sharma, ... Biomaterials 125, 38-53, 2017 | 141 | 2017 |
Transfer of PAMAM dendrimers across human placenta: prospects of its use as drug carrier during pregnancy AR Menjoge, AL Rinderknecht, RS Navath, M Faridnia, CJ Kim, ... Journal of controlled release 150 (3), 326-338, 2011 | 137 | 2011 |
Dendrimer nanoparticles for ocular drug delivery SP Kambhampati, RM Kannan Journal of Ocular Pharmacology and Therapeutics 29 (2), 151-165, 2013 | 135 | 2013 |